Biotech | March 16, 2026
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
The endorsement follows overwhelming support for the share swap preceding the merger,
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The collaboration will leverage this clinical experience to inform NCEL-101 development, streamline regulatory pathways, and potentially accelerate timelines for achieving durable graft survival comparable to donor human islets
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
Cognita CXR leverages a proprietary vision-language model to analyze full chest X-ray studies and generate comprehensive preliminary findings
Subscribe To Our Newsletter & Stay Updated
